We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Sues Perrigo, Catalent to Halt ANDA Plans for Asthma Drug
Teva Sues Perrigo, Catalent to Halt ANDA Plans for Asthma Drug
September 11, 2012
Teva is suing Perrigo and Catalent Pharma Solutions to stop the companies’ plans to market and develop generic versions of its asthma drug ProAir HFA before two key patents pop.